Enoxaparin sodium and Exercise tolerance decreased - a phase IV clinical study of FDA data

Summary:

Exercise tolerance decreased is reported as a side effect among people who take Enoxaparin sodium (enoxaparin sodium), especially for people who are male, 60+ old, also take Allopurinol, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Exercise tolerance decreased when taking Enoxaparin sodium. It is created by eHealthMe based on reports of 24,091 people who have side effects when taking Enoxaparin sodium from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Exercise tolerance decreased?

Exercise tolerance decreased is found to be associated with 627 drugs and 723 conditions by eHealthMe. Check the latest studies of Exercise tolerance decreased.

On Jul, 07, 2026

24,091 people reported to have side effects when taking Enoxaparin sodium.
Among them, 12 people (0.05%) have Exercise tolerance decreased.

Could Enoxaparin sodium cause Exercise tolerance decreased?

Among these 12 people:

What is the gender of people who have Exercise tolerance decreased when taking Enoxaparin sodium? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Exercise tolerance decreased when taking Enoxaparin sodium? *

What are other drugs people take besides Enoxaparin sodium? *

What are other side effects people have besides Exercise tolerance decreased? *

Nausea (feeling of having an urge to vomit): 10 people, 83.33%
Cough: 9 people, 75.00%
Diarrhea: 9 people, 75.00%
Rashes (redness): 8 people, 66.67%
Fatigue (feeling of tiredness): 7 people, 58.33%
Cardiac Failure: 7 people, 58.33%
Dyspnea (difficult or laboured breathing): 6 people, 50.00%
Sinusitis (inflammation of sinus): 6 people, 50.00%
Fainting (loss of consciousness and postural tone): 5 people, 41.67%
Hyperventilation: 4 people, 33.33%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 41.67%
High Blood Pressure: 4 people, 33.33%
Disease Recurrence: 3 people, 25.00%
Hair Loss: 2 people, 16.67%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 8.33%
Fungal Infection: 1 person, 8.33%
Cardiac Disorder: 1 person, 8.33%
Bruton's Agammaglobulinaemia (low or completely absent levels of immunoglobulins in the bloodstream): 1 person, 8.33%
Blood Glucose Increased: 1 person, 8.33%
Analgesia: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and have Exercise tolerance decreased?

- Check whether Exercise tolerance decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enoxaparin sodium:

Enoxaparin sodium (24,181 reports)

Browse all side effects of Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (627 drugs)

Browse all the conditions that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Enoxaparin sodium) and Enoxaparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.